Skip to main content

Myocardial tissue characterization in ischemic heart disease


Neuer Inhalt © myesr.org


CALL FOR PAPERS

The thematic series “Myocardial tissue characterization in ischemic heart disease” is currently open for further submissions on this topic. The guest editors, Akos Varga-Szemes and Pal S. Suranyi (MUSC, Charleston/US), are looking forward to receiving your contribution.

Neuer Inhalt A. Varga-Szemes       Neuer Inhalt P. Suranyi

Ischemic heart disease remains a leading cause of mortality worldwide and an increasing health problem in developed and developing countries alike. Advanced imaging modalities are increasingly becoming essential tools in the diagnosis and management of ischemic heart disease. This thematic series provides an overview of the well-established imaging modalities in ischemic heart disease, alongside recent advances, and ongoing developments in the field.

Submit your paper at www.editorialmanager.com/EURE



  1. Ischemic heart disease and its sequelae are one of the major contributors to morbidity and mortality worldwide. Over the last decades, technological developments have strengthened the role of noninvasive imagi...

    Authors: Tilman Emrich, Moritz Halfmann, U. Joseph Schoepf and Karl-Friedrich Kreitner
    Citation: European Radiology Experimental 2021 5:14
  2. After an ischemic event, disruptive changes in the healthy myocardium may gradually develop and may ultimately turn into fibrotic scar. While these structural changes have been described by conventional imagin...

    Authors: Martin J. Willemink, Akos Varga-Szemes, U. Joseph Schoepf, Marina Codari, Koen Nieman, Dominik Fleischmann and Domenico Mastrodicasa
    Citation: European Radiology Experimental 2021 5:12
  3. This review provides an overview of the currently available computed tomography (CT) techniques for myocardial tissue characterization in ischemic heart disease, including CT perfusion and late iodine enhancem...

    Authors: M. van Assen, M. Vonder, G. J. Pelgrim, P. L. Von Knebel Doeberitz and R. Vliegenthart
    Citation: European Radiology Experimental 2020 4:36
  4. Contrast-enhanced cardiac magnetic resonance (CMR) is pivotal for evaluating chronic myocardial infarction (CMI). Concerns about safety of gadolinium-based contrast agents favour dose reduction. We assessed im...

    Authors: Caterina Beatrice Monti, Marina Codari, Andrea Cozzi, Marco Alì, Lorenzo Saggiante, Francesco Sardanelli and Francesco Secchi
    Citation: European Radiology Experimental 2020 4:21